OCULIS ANNOUNCES POSITIVE TOP LINE RESULTS FROM DIAMOND STAGE 1 PHASE 3 TRIAL IN DIABETIC MACULAR EDEMA WITH OCS-01 EYE DROPS

Drug Farm Raises $27M USD Financing for Advancement of First-In-Class Hepatitis B and Cardiovascular-Renal Drugs into Clinical Trials

Oculis Announces US Public Listing on NASDAQ

BVCF Portfolio | DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.

Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies

Oculis Announces an Oversubscribed US$57 million Series C Financing

Boan Biotech Completed a New Round of Financing, Accelerating Global Development of Its Biopharmaceutical Business

Acuvu Completed 100 Million RMB in Series B Financing to Promote Innovation in Disposable Endoscope Products and Accelerate Global Distribution

Biocytogen Submitted Form to Hong Kong Stock Exchange for IPO Application

Biocytogen Announced Completion of New Round of Financing of Multi-Dozen Millions of Dollars to Build R&D Engine for Antibody Drugs

CARsgen Therapeutics officially listing on HKEX

Allgen Listed on STAR Market, Stock Price Surging over 472%

Drug Farm Closes $56M USD Financing for Advancement of Lead Hepatitis B Drug into Clinical Trials

Yidu Technology Listed on the Hong Kong Stock Exchange

CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates

Ruibo Completed C+ Round of Financing of 250 Million RMB

Biocytogen Announced the Completion of 970 Million RMB in D+ Round of Financing

Cathay Biotech Inc.(688065.SH) officially listed on the STAR Market

MicuRx Closes nearly $43M series D financing to accelerate the preparation of commercialization

Novast Completed Nearly One Billion RMB Private Equity Financing

Ruibo Biotech Secured 470 million RMB in C2 Round of Financing